The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: A 10-year longitudinal study

Arthritis Research and Therapy

Volumn 10, Issue 3, 2008, Pages

  Provan, Sella A ^a   Angel, Kristin ^b,c   Ødegård, Sigrid ^a   Mowinckel, Petter ^a   Atar, Dan ^b,c   Kvien, Tore K ^a,b  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOOXYGENASE 2 INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; IMMUNOGLOBULIN M; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; JOINT SWELLING; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 47149102199     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2442     Document Type: Article

References (36)

1. Solomon DH Karlson EW Rimm EB Cannuscio CC Mandl LA Manson JE Stampfer MJ Curhan GC Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Circulation 2003, 107:1303-1307. 10.1161/ 01.CIR.0000054612.26458.B2 12628952
2. del Rincón ID Williams K Stern MP Freeman GL Escalante A High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 2001, 44:2737-2745. 10.1002/ 1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# 11762933
3. Turesson C McClelland RL Christianson TJ Matteson EL Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis Ann Rheum Dis 2007, 66:70-75. 10.1136/ard.2006.052506 16877533
4. Farragher TM Lunt M Bunn DK Silman AJ Symmons DP Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: Results from the Norfolk Arthritis Register Ann Rheum Dis 2007, 66:486-492. 10.1136/ ard.2006.056390 17090565
5. Wållberg-Jonsson S Johansson H Ohman ML Rantapää-Dahlqvist S Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset J Rheumatol 1999, 26:2562-2571. 10606363
6. Wolfe F Michaud K Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy Am J Med 2004, 116:305-311. 10.1016/j.amjmed.2003.09.039 14984815
7. Nicola PJ Maradit-Kremers H Roger VL Jacobsen SJ Crowson CS Ballman KV Gabriel SE The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years Arthritis Rheum 2005, 52:412-420. 10.1002/art.20855 15692992
8. Maradit-Kremers H Nicola PJ Crowson CS Ballman KV Jacobsen SJ Roger VL Gabriel SE Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis Ann Rheum Dis 2007, 66:76-80. 10.1136/ard.2006.053710 16818462
9. Bibbins-Domingo K Ansari M Schiller NB Massie B Whooley MA B-type natriuretic peptide and ischemia in patients with stable coronary disease: Data from the Heart and Soul study Circulation 2003, 108:2987-2992. 10.1161/01.CIR.0000103681.04726.9C 14662720
10. Kragelund C Gronning B Kober L Hildebrandt P Steffensen R N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease N Engl J Med 2005, 352:666-675. 10.1056/ NEJMoa042330 15716560
11. Wang TJ Larson MG Levy D Benjamin EJ Leip EP Omland T Wolf PA Vasan RS Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 2004, 350:655-663. 10.1056/NEJMoa031994 14960742
12. Bettencourt P Azevedo A Pimenta J Frioes F Ferreira S Ferreira A N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 2004, 110:2168-2174. 10.1161/01.CIR.0000144310.04433.BE 15451800
13. Tschope C Kasner M Westermann D Gaub R Poller WC Schultheiss HP The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements Eur Heart J 2005, 26:2277-2284. 10.1093/eurheartj/ehi406 16014646
14. McKie PM Burnett JC Jr B-type natriuretic peptide as a biomarker beyond heart failure: Speculations and opportunities Mayo Clin Proc 2005, 80:1029-1036. 16092582
15. Smedstad LM Vaglum P Kvien TK Moum T The relationship between self-reported pain and sociodemographic variables, anxiety, and depressive symptoms in rheumatoid arthritis J Rheumatol 1995, 22:514-520. 7783072
16. Ritchie DM Boyle JA McInnes JM Jasani MK Dalakos TG Grieveson P Buchanan WW Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis Q J Med 1968, 37:393-406. 4877784
17. Prevoo ML van't Hof MA Kuper HH van Leeuwen MA Putte van de LB van Riel PL Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107 7818570
18. Fries JF Spitz P Kraines RG Holman HR Measurement of patient outcome in arthritis Arthritis Rheum 1980, 23:137-145. 10.1002/art.1780230202 7362664
19. Meenan RF Gertman PM Mason JH Measuring health status in arthritis. The arthritis impact measurement scales Arthritis Rheum 1980, 23:146-152. 10.1002/art.1780230203 7362665
20. Heijde van der DM Plain X-rays in rheumatoid arthritis: Overview of scoring methods, their reliability and applicability Baillieres Clin Rheumatol 1996, 10:435-453. 8876953
21. Syversen SW Gaarder PI Goll GL Ødegård S Haavardsholm EA Mowinckel P Heijde van der D Landewé R Kvien TK High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: Results from a 10-year longitudinal study Ann Rheum Dis 2008, 67:212-217. 10.1136/ard.2006.068247 17526555
22. Raymond I Groenning BA Hildebrandt PR Nilsson JC Baumann M Trawinski J Pedersen F The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population Heart 2003, 89:745-751. 1767734 12807847 10.1136/ heart.89.7.745
23. Chan YH Biostatistics 301A. Repeated measurement analysis (mixed models) Singapore Med J 2004, 45:456-461. 15455165
24. Richards M Nicholls MG Espiner EA Lainchbury JG Troughton RW Elliott J Frampton CM Crozier IG Yandle TG Doughty R MacMahon S Sharpe N Christchurch Cardioendocrine Research Group; Australia-New Zealand Heart Failure Group Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease J Am Coll Cardiol 2006, 47:52-60. 10.1016/j.jacc.2005.06.085 16386664
25. Harney SM Timperley J Daly C Harin A James T Brown MA Banning AP Fox K Donnelly S Wordsworth BP Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis Ann Rheum Dis 2006, 65:136. 10.1136/ ard.2005.040634 16344502
26. Ridker PM Buring JE Cook NR Rifai N C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women Circulation 2003, 107:391-397. 10.1161/01.CIR.0000055014.62083.05 12551861
27. Vasan RS Sullivan LM Roubenoff R Dinarello CA Harris T Benjamin EJ Sawyer DB Levy D Wilson PW D'Agostino RB Framingham Heart Study Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: The Framingham Heart Study Circulation 2003, 107:1486-1491. 10.1161/01.CIR.0000057810.48709.F6 12654604
28. van Leeuwen MA van Rijswijk MH Heijde van der DM Te Meerman GJ van Riel PL Houtman PM Putte van De LB Limburg PC The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease Br J Rheumatol 1993, 32(Suppl 3):9-13. 8508266
29. Wick MC Lindblad S Klareskog L Van Vollenhoven RF Relationship between inflammation and joint destruction in early rheumatoid arthritis: A mathematical description Ann Rheum Dis 2004, 63:848-852. 1755049 15194582 10.1136/ard.2003.015172
30. van Leeuwen MA van Rijswijk MH Sluiter WJ van Riel PL Kuper IH Putte van de LB Pepys MB Limburg PC Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system J Rheumatol 1997, 24:20-27. 9002006
31. Ødegård S Landewé R Heijde van der Kvien TK Mowinckel P Uhlig T Association of early radiographic damage with impaired physical function in rheumatoid arthritis: A ten-year, longitudinal observational study in 238 patients Arthritis Rheum 2006, 54:68-75. 10.1002/art.21548 16385497
32. Maradit-Kremers H Nicola PJ Crowson CS Ballman KV Gabriel SE Cardiovascular death in rheumatoid arthritis: A population-based study Arthritis Rheum 2005, 52:722-732. 10.1002/art.20878 15751097
33. Book C Saxne T Jacobsson LT Prediction of mortality in rheumatoid arthritis based on disease activity markers J Rheumatol 2005, 32:430-434. 15742433
34. Hobbs FD Davis RC Roalfe AK Hare R Davies MK Kenkre JE Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: Cohort study in representative and high risk community populations BMJ 2002, 324:1498. 116449 12077039 10.1136/bmj.324.7352.1498
35. Galasko GI Lahiri A Barnes SC Collinson P Senior R What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 2005, 26:2269-2276. 10.1093/eurheartj/ehi410 16040618
36. St Peter JV Hartley GG Murakami MM Apple FS B-type natriuretic peptide (BNP) and N-terminal pro-BNP in obese patients without heart failure: relationship to body mass index and gastric bypass surgery Clin Chem 2006, 52:680-685. 10.1373/clinchem.2005.062562 16497939